Takeo Ishiguro

951 total citations
32 papers, 609 citations indexed

About

Takeo Ishiguro is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Takeo Ishiguro has authored 32 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Psychiatry and Mental health, 19 papers in Cellular and Molecular Neuroscience and 13 papers in Pharmacology. Recurrent topics in Takeo Ishiguro's work include Neurotransmitter Receptor Influence on Behavior (18 papers), Treatment of Major Depression (12 papers) and Neuroscience and Neuropharmacology Research (9 papers). Takeo Ishiguro is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (18 papers), Treatment of Major Depression (12 papers) and Neuroscience and Neuropharmacology Research (9 papers). Takeo Ishiguro collaborates with scholars based in Japan and United States. Takeo Ishiguro's co-authors include Koichi Nisijima, Shigenori Ikemoto, Kunio Yui, Kimihiko Goto, Kunio Gotō, Brian Sheitman, G E Duncan, Burton Angrist, Syed F. Ali and Jeffrey A. Lieberman and has published in prestigious journals such as Biological Psychiatry, Annals of the New York Academy of Sciences and Journal of Neurochemistry.

In The Last Decade

Takeo Ishiguro

31 papers receiving 567 citations

Peers

Takeo Ishiguro
Ryosuke Miyatake Japan
Faiq A. Hameedi United States
Kenneth B. Kashkin United States
Chih-Ken Chen Taiwan
Atapol Sughondhabirom Thailand
Christian Barnas Austria
A Lerner Israel
Maria J. Sarrias Spain
Elena Marino Italy
G. Remington Canada
Ryosuke Miyatake Japan
Takeo Ishiguro
Citations per year, relative to Takeo Ishiguro Takeo Ishiguro (= 1×) peers Ryosuke Miyatake

Countries citing papers authored by Takeo Ishiguro

Since Specialization
Citations

This map shows the geographic impact of Takeo Ishiguro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeo Ishiguro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeo Ishiguro more than expected).

Fields of papers citing papers by Takeo Ishiguro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeo Ishiguro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeo Ishiguro. The network helps show where Takeo Ishiguro may publish in the future.

Co-authorship network of co-authors of Takeo Ishiguro

This figure shows the co-authorship network connecting the top 25 collaborators of Takeo Ishiguro. A scholar is included among the top collaborators of Takeo Ishiguro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeo Ishiguro. Takeo Ishiguro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yui, Kunio, Shigenori Ikemoto, Takeo Ishiguro, & Kimihiko Goto. (2000). Studies of Amphetamine or Methamphetamine Psychosis in Japan: Relation of Methamphetamine Psychosis to Schizophrenia. Annals of the New York Academy of Sciences. 914(1). 1–12. 77 indexed citations
3.
4.
Yui, Kunio, Takeo Ishiguro, Kimihiko Goto, & Shigenori Ikemoto. (2000). Susceptibility to Subsequent Episodes in Spontaneous Recurrence of Methamphetamine Psychosis. Annals of the New York Academy of Sciences. 914(1). 292–302. 13 indexed citations
5.
Nisijima, Koichi, et al.. (2000). Risperidone counteracts lethality in an animal model of the serotonin syndrome. Psychopharmacology. 150(1). 9–14. 52 indexed citations
6.
Yui, Kunio, Kimihiko Goto, Shigenori Ikemoto, & Takeo Ishiguro. (2000). Stress induced spontaneous recurrence of methamphetamine psychosis: the relation between stressful experiences and sensitivity to stress. Drug and Alcohol Dependence. 58(1-2). 67–75. 15 indexed citations
7.
Yui, Kunio, et al.. (1999). Increased sensitivity to stress and episode recurrence in spontaneous recurrence of methamphetamine psychosis. Psychopharmacology. 145(3). 267–272. 12 indexed citations
8.
Yui, Kunio, Takeo Ishiguro, Kunio Gotō, Shigenori Ikemoto, & Yasuyuki Kamata. (1999). Spontaneous recurrence of methampetamine psychosis: increased sensitivity to stress associated with noradrenergic hyperactivity and dopaminergic change. European Archives of Psychiatry and Clinical Neuroscience. 249(2). 103–111. 14 indexed citations
9.
Yui, Kunio, Kunio Gotō, Shigenori Ikemoto, et al.. (1999). Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization. Molecular Psychiatry. 4(6). 512–523. 80 indexed citations
10.
Ishiguro, Takeo, et al.. (1998). Treatment of tardive dystonia with an antispastic agent. Acta Psychiatrica Scandinavica. 98(4). 341–343. 5 indexed citations
11.
Nisijima, Koichi, et al.. (1998). Addition of carbamazepine to long-term treatment with neuroleptics may induce neuroleptic malignant syndrome. Biological Psychiatry. 44(9). 930–931. 9 indexed citations
12.
Yui, Kunio, Takeo Ishiguro, Kunio Gotō, & Shigenori Ikemoto. (1998). Factors affecting the development of spontaneous recurrence of methamphetamine psychosis. Acta Psychiatrica Scandinavica. 97(3). 220–227. 1 indexed citations
13.
Yui, Kunio, Takeo Ishiguro, Kimihiko Goto, & Shigenori Ikemoto. (1997). Precipitating factors in spontaneous recurrence of methamphetamine psychosis. Psychopharmacology. 134(3). 303–308. 14 indexed citations
14.
Kato, Satoshi & Takeo Ishiguro. (1997). Clinical Courses of Hypochondriac-Cenesthopathic Symptoms in Schizophrenia. Psychopathology. 30(2). 76–82. 8 indexed citations
15.
Yui, Kunio, Kimihiko Goto, Shigenori Ikemoto, & Takeo Ishiguro. (1997). Methamphetamine Psychosis. Journal of Clinical Psychopharmacology. 17(1). 34–43. 41 indexed citations
16.
Yui, Kunio, Kimihiko Goto, Shigenori Ikemoto, & Takeo Ishiguro. (1996). Monoamine Neurotransmitter Function and Spontaneous Recurrence of Methamphetamine Psychosis. Annals of the New York Academy of Sciences. 801(1). 415–429. 5 indexed citations
17.
Shimizu, Motohiro, et al.. (1996). A case of serotonin syndrome induced by concomitant treatment with low dose trazodone and amitriptyline and lithium. International Clinical Psychopharmacology. 11(4). 289–290. 25 indexed citations
18.
Yui, Kunio, Kimihiko Goto, Shigenori Ikemoto, & Takeo Ishiguro. (1996). Plasma monoamine metabolites and spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory psychosis: relation of noradrenergic activity to the occurrence of flashbacks. Psychiatry Research. 63(2-3). 93–107. 7 indexed citations
19.
Matoba, M., et al.. (1994). Single photon emission computed tomography with123I-IMP in three cases of the neuroleptic malignant syndrome. Neuroradiology. 36(4). 281–284. 3 indexed citations
20.
Nisijima, Koichi & Takeo Ishiguro. (1993). Does dantrolene influence central dopamine and serotonin metabolism in the neuroleptic malignant syndrome? A retrospective study. Biological Psychiatry. 33(1). 45–48. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryosuke Miyatake Breakdown of academic impact, for papers by Faiq A. Hameedi Breakdown of academic impact, for papers by Kenneth B. Kashkin Breakdown of academic impact, for papers by Chih-Ken Chen Breakdown of academic impact, for papers by Atapol Sughondhabirom Breakdown of academic impact, for papers by Christian Barnas Breakdown of academic impact, for papers by A Lerner Breakdown of academic impact, for papers by Maria J. Sarrias Breakdown of academic impact, for papers by Elena Marino Breakdown of academic impact, for papers by G. Remington
Rankless by CCL
2026